[LGND] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
09-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -55.34%
YoY- 304.79%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 57,419 45,693 72,473 64,835 84,675 55,150 69,990 -12.39%
PBT -636 -20,140 -7,026 15,259 33,301 5,764 3,370 -
Tax 259 -4,755 -2,058 1,536 2,576 -12,342 -2,391 -
NP -895 -15,385 -4,968 13,723 30,725 18,106 5,761 -
Tax Rate - - - -10.07% -7.74% 214.12% 70.95% -
Total Cost 58,314 61,078 77,441 51,112 53,950 37,044 64,229 -6.25%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -1.56 -33.67 -6.85 21.17 36.29 32.83 8.23 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.05 -0.92 -0.30 0.82 1.84 1.10 0.36 -
EPS Diluted -0.05 -0.91 -0.30 0.80 1.79 1.05 0.35 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.